Peyman Ghasri, M.D.
NPI 1265498034 · Specialist · Encino, CA
Enrolled with Medicare as Practitioner - Dermatology · source: CMS PECOS Public Provider Enrollment (2026.04.01)
Peyman Ghasri, M.D. is a Specialist provider in Encino, CA (NPI 1265498034).
Provider details
- NPI number
- 1265498034
- Entity type
- Individual
- Primary specialty
- SpecialistOther Service Providers
- Credential
- M.D.
- Sex
- Male
- Sole proprietor
- No
- License
- A83809 (CA)
Specialties & taxonomies
Other Service Providers
Profile Score
A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.
- Registry tenure25% of score
20 yrs in NPPES registry
- Profile completeness25% of score
100% of core fields populated
- Practice footprint15% of score
1 documented practice location
- Medicare service volume (vs. specialty peers)25% of score
17,672 Medicare services, 2024 (ranked within specialty)
- Open Payments transparency10% of score
Has Open Payments disclosures (2024)
Medicare volume is ranked against active providers in the same specialty. Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our .
What this provider does (Medicare)
Based on Medicare fee-for-service claims, 2024; not all care is captured.
| Service (HCPCS) | Medicare services | Typical Medicare-allowed (2024) |
|---|---|---|
| Destruction of Precancer Skin Growth, 2-14 Growths17003 | 8,190 | $8 |
| Established Patient Office Or Other Outpatient Visit With Moderate Level of Decision Making, If Using Time, 30 Minutes Or More99214 | 1,810 | $146 |
| Destruction of Skin Growth, 1-14 Growths17110 | 1,239 | $127 |
| Established Patient Office Or Other Outpatient Visit With Low Level OD Decision Making, If Using Time, 20 Minutes Or More99213 | 1,162 | $104 |
| Destruction of Precancer Skin Growth, 1 Growth17000 | 1,032 | $49 |
| Biopsy of Related Skin Growth, First Growth |
What this provider prescribes (Medicare Part D)
Top drugs by Medicare Part D claim volume, 2024 · 42 distinct drugs on file.
| Drug | Part D claims (2024) | Beneficiaries |
|---|---|---|
| Ketoconazole | 557 | 245 |
| Triamcinolone Acetonide | 508 | 320 |
| Betamethasone/Propylene Glycbrand: Betamethasone Diprop Augmented | 284 | 179 |
| Mupirocin | 211 | 168 |
| Clobetasol Propionate | 188 | 94 |
| Doxycycline Hyclate | 167 | 78 |
| Hydrocortisone | 165 | 121 |
| Fluocinonide |
Transparency — industry payments
Based on CMS Open Payments, 2024; not all care is captured.
$2,691 across 135 records (Open Payments 2024)
Open Payments discloses payments and transfers of value (meals, travel, consulting, research, royalties) from drug and device makers to providers. This is a transparency signal, not a verdict — such payments are legal and common, and their presence is neither an endorsement nor a criticism. Source: CMS Open Payments, program year 2024.
Practice location
Mailing address
Registry dates
- Enumerated
- 2006-04-21
- Last updated
- 2020-02-18
- Certified
- 2020-02-18
Frequently asked questions
- What is Peyman Ghasri's NPI number?
- Peyman Ghasri's National Provider Identifier (NPI) is 1265498034, a unique 10-digit ID issued by CMS for use in standard healthcare transactions.
- What is Peyman Ghasri's specialty?
- Peyman Ghasri is listed in the NPPES registry with a primary specialty of Specialist (Other Service Providers).
- Where is Peyman Ghasri located?
- Peyman Ghasri's practice location on file with NPPES is 5363 Balboa Blvd, Encino, CA 91316-2805.
- What is Peyman Ghasri's phone number?
- The practice phone number listed in the NPPES registry for Peyman Ghasri is (818) 501-3376.
- Does Peyman Ghasri accept Medicare?
- Peyman Ghasri is approved to bill Medicare according to CMS PECOS enrollment data (2026.04.01). Confirm current participation with the provider before scheduling.
- Is Peyman Ghasri's NPI active?
- Yes — Peyman Ghasri's NPI (1265498034) is active in the NPPES registry as of the last update on 2020-02-18.
Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.